Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Hernani, Rafael  [Clear All Filters]
Journal Article
Huntley D, Talaya A, Giménez E, Martínez A, Hernández-Boluda JCarlos, Hernani R, Torres I, Alberola J, Albert E, Piñana JLuis, et al. Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive Antiviral Therapy Strategies. Biol Blood Marrow Transplant. 2020.
Huntley D, Giménez E, Vázquez L, Pascual MJesús, Amat P, Remigia MJosé, Hernández-Boluda JCarlos, García M, Gago B, Torres I, et al. Impact of cytomegalovirus immunodominant HLA-I donor-recipient matching on the incidence and features of virus DNAemia and virus-specific T-cell immune reconstitution in unmanipulated haploidentical hematopoietic stem cell transplantation. Transpl Infect Dis. 2023:e14065.
Bueno F, Albert E, Piñana JLuis, Pérez A, Úbeda C, Gómez MDolores, Hernández-Boluda JCarlos, Gonzalez-Barberá EMaría, Montoro J, Giménez E, et al. Kinetics of Torque Teno virus DNA in stools may predict occurrence of acute intestinal graft versus host disease early after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2020:e13507.
Forqué L, Albert E, Piñana JL, Pérez A, Hernani R, Solano C, Navarro D, Giménez E. Monitoring of plasma Torque teno virus, total Anelloviridae and Human Pegivirus 1 viral load for the prediction of infectious events and acute graft versus host disease in the allogeneic hematopoietic stem cell transplantation setting. J Med Virol. 2023;95(9):e29107.
Rejeski K, Burchert A, Iacoboni G, Sesques P, Fransecky L, Buecklein V, Trenker C, Hernani R, Naumann R, Schäfer JA, et al. Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy. Blood Adv. 2022.
Piñana JLuis, López-Corral L, Martino R, Montoro J, Vázquez L, Pérez A, Martin-Martin G, Facal-Malvar A, Ferrer E, Pascual M-J, et al. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC). Am J Hematol. 2021.